Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.68B |
| 2 |
Synchrony
SYF
|
+$441M |
| 3 |
Meta Platforms (Facebook)
META
|
+$370M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$349M |
| 5 |
Comcast
CMCSA
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$783M |
| 2 |
Morgan Stanley
MS
|
+$518M |
| 3 |
Lowe's Companies
LOW
|
+$474M |
| 4 |
Visa
V
|
+$425M |
| 5 |
Netflix
NFLX
|
+$419M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.01% |
| 2 | Technology | 4.76% |
| 3 | Consumer Discretionary | 3.82% |
| 4 | Industrials | 3.81% |
| 5 | Communication Services | 3.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AIMT
2901
DELISTED
Aimmune Therapeutics
AIMT
| $4.15M | ﹤0.01% |
173,679
+133,564
| +333% | +$3.46M |
|
|
ESL
2902
CALL
DELISTED
Esterline Technologies
ESL
| $4.15M | ﹤0.01% |
34,200
+12,900
| +61% | +$1.49M |
|
2903
PUT
Eastman Chemical
EMN
$8.47B
| $4.15M | ﹤0.01% |
56,800
+2,200
| +4% | +$175K |
|
2904
Lamar Advertising Co
LAMR
$15.8B
| $4.15M | ﹤0.01% |
59,939
-899,164
| -94% | -$66.1M |
|
2905
BCE
BCE
$21.9B
| $4.14M | ﹤0.01% |
104,677
+74,377
| +245% | +$3.04M |
|
2906
Coeur Mining
CDE
$19.3B
| $4.14M | ﹤0.01% |
925,804
-5,082
| -0.5% | -$24K |
|
|
ACOR
2907
DELISTED
Acorda Therapeutics
ACOR
| $4.14M | ﹤0.01% |
+2,212
| New | +$4.81M |
|
2908
Vericel Corp
VCEL
$2.26B
| $4.13M | ﹤0.01% |
237,632
+145,566
| +158% | +$2.18M |
|
2909
CALL
Edison International
EIX
$27.5B
| $4.13M | ﹤0.01% |
72,800
+55,200
| +314% | +$3.43M |
|
|
OPLN
2910
CALL
Openlane
OPLN
$4.33B
| $4.13M | ﹤0.01% |
228,797
+99,603
| +77% | +$2.07M |
|
|
FIT
2911
PUT
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $4.13M | ﹤0.01% |
830,900
-220,500
| -21% | -$1.14M |
|
2912
CALL
Sanofi
SNY
$105B
| $4.13M | ﹤0.01% |
95,100
-11,000
| -10% | -$485K |
|
2913
CALL
HF Sinclair
DINO
$16.7B
| $4.12M | ﹤0.01% |
80,600
-55,000
| -41% | -$3.37M |
|
|
AXON
2914
PUT
Axon Enterprise
AXON
$49.8B
| $4.12M | ﹤0.01% |
94,100
-43,600
| -32% | -$2.26M |
|
2915
SiteOne Landscape Supply
SITE
$4.3B
| $4.11M | ﹤0.01% |
+74,429
| New | +$4.67M |
|
2916
InterContinental Hotels
IHG
$23.6B
| $4.11M | ﹤0.01% |
+71,531
| New | +$4.12M |
|
2917
Tenet Healthcare
THC
$21.6B
| $4.11M | ﹤0.01% |
239,713
-189,930
| -44% | -$4.6M |
|
2918
PUT
Consolidated Edison
ED
$40.2B
| $4.11M | ﹤0.01% |
53,700
-26,400
| -33% | -$2.06M |
|
2919
CALL
Galicia Financial Group
GGAL
$6.97B
| $4.1M | ﹤0.01% |
148,700
+9,000
| +6% | +$229K |
|
2920
Aclaris Therapeutics
ACRS
$851M
| $4.1M | ﹤0.01% |
554,338
-328,026
| -37% | -$3.38M |
|
2921
PUT
KKR & Co
KKR
$102B
| $4.09M | ﹤0.01% |
208,400
+89,200
| +75% | +$2.04M |
|
2922
PUT
Marvell Technology
MRVL
$199B
| $4.09M | ﹤0.01% |
252,600
-296,800
| -54% | -$4.92M |
|
2923
CALL
Bread Financial
BFH
$4.58B
| $4.08M | ﹤0.01% |
34,082
-1,754
| -5% | -$275K |
|
2924
CALL
Labcorp
LH
$25.8B
| $4.08M | ﹤0.01% |
37,597
+2,444
| +7% | +$327K |
|
2925
IQVIA
IQV
$39B
| $4.08M | ﹤0.01% |
35,104
-508,587
| -94% | -$61.6M |
|
Similar funds
Ken Griffin's Q4 2018 Portfolio in Review
As of Q4 2018, Ken Griffin held 10,385 positions worth $183B, down 19% from $224B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ken Griffin withdrew a net $8B in Q4 2018, closing 1,371 positions and reducing 3,800 holdings. Its most notable exit was Aetna Inc, an estimated $783M position sold in full.
By sector, the portfolio is most concentrated in Financials at 5% of assets, down from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Assurant worth $99.4M.
- Ken Griffin's largest Q4 2018 buy was Assurant: 1,111,342 shares worth $99.4M.
- Ken Griffin added most to Amazon in Q4 2018, an estimated $1.68B increase.
- Ken Griffin's biggest Q4 2018 reduction was Morgan Stanley, cutting an estimated $518M.
- Ken Griffin fully exited Aetna Inc in Q4 2018, selling an estimated $783M.
- Ken Griffin's ten largest holdings make up 24% of its $183B portfolio in Q4 2018.
- Ken Griffin opened 1,236 new positions and closed 1,371 in Q4 2018.
- Ken Griffin's portfolio value fell 19% quarter-over-quarter to $183B.
Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.